BioSpace News Archive

The swabs collection kit market is expected to grow from US$ 4141.32 million in 2021 to US$ 5641.68 million by 2028; it is estimated to register a CAGR of 4.5% from 2021 to 2028.

HAGAR, the developer of GWave, the world’s first non-invasive continuous glucose monitoring technology that uses RF waves to measure glucose levels in the blood, today announced an $11.7 million Series B funding round led by a returning investor, Columbia Pacific.

Sperm bank is facility that does the function of collection, freezing and storage of sperms so that they can be used in future.

Sen-Jam, a life-science startup led by Registered Pharmacist Jacqueline Iversen, has partnered with researcher Ashley St. John PhD of the Duke-NUS Medical School in Singapore, to trial a novel combination of two proven drug molecules that may work pre-emptively to stop the progression of COVID to the Severe Acute Respiratory Syndrome (SARS) stage.

ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, today announced its unaudited financial results for the quarter ended June 30, 2021.

Eargo, Inc., a medical device company on a mission to improve the quality of life of people with hearing loss, reported its financial results for the second quarter ended June 30, 2021.

AVITA Medical, Inc., a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced it plans to release its fiscal fourth quarter 2021 financial results after the market closes on Thursday, August 26, 2021.

Lyell Immunopharma, Inc. (Lyell), (Nasdaq: LYEL), a T cell reprogramming company dedicated to the mastery of T cells to cure patients with solid tumors, today reported financial results for the second quarter and first six months of 2021 and provided business highlights.

miR Scientific, LLC announces the appointment of Erik Johnson, a seasoned leader in pharma and oncology, as Chief Operating Officer.

Medcura, Inc., a commercial-stage medical device company, today announced it has raised $7.4 million in private equity to support its growing product line and development of its lead surgical candidate for clinical evaluation.